NCT02832128View on ClinicalTrials.gov

Evaluating Possible Improvement in Speech and Hearing Tests After 28 Days of Dosing of the Study Drug AUT00063 Compared to Placebo (QuicKfire)

PHASE2CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

May 31, 2016

Primary Completion Date

April 30, 2017

Study Completion Date

April 30, 2017

Conditions
Hearing LossHearing Impairment
Interventions
DRUG

AUT00063

4 capsules of 200 mg AUT00063, to take orally with food for 4 weeks

DRUG

Placebo

4 capsules of placebo, to take orally with food for 4 weeks

Trial Locations (4)

Unknown

University Hospitals Birmingham NHS Foundation Trust, Birmingham

Cambridge University Hospitals NHS Foundation Trust, Cambridge

Royal National Throat, Nose and Ear Hospital, London

Manchester Royal Infirmary, Manchester

Sponsors
All Listed Sponsors
lead

Autifony Therapeutics Limited

INDUSTRY

NCT02832128 - Evaluating Possible Improvement in Speech and Hearing Tests After 28 Days of Dosing of the Study Drug AUT00063 Compared to Placebo (QuicKfire) | Biotech Hunter | Biotech Hunter